Literature DB >> 21621645

Nickel allergy-promoting effects of microbial or inflammatory substances at the sensitization step in mice.

Harue Takahashi1, Masayuki Kinbara, Naoki Sato, Keiichi Sasaki, Shunji Sugawara, Yasuo Endo.   

Abstract

Microbial components stimulate innate immunity via Toll-like receptors (TLRs), nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), and/or IL-1. We recently reported that in mice, Escherichia coli lipopolysaccharide (LPS, TLR4-ligand) promotes allergic responses to nickel (Ni) at both the sensitization and elicitation steps. Here, we examined in mice the effects of administering other microbial or inflammatory materials at the Ni-sensitization step. A mixture of 1mM NiCl(2) and a test solution was injected into BALB/c mice intraperitoneally (0.1 ml/10 g body weight), and 10 days later 5mM NiCl(2) was challenged intradermally into the ear pinnas of the mice (20 μl/ear). The following preparations or substances exhibited adjuvant activities: Prevotella intermedia LPS, Saccharomyces cerevisiae mannan, a synthetic muramyl dipeptide (NOD2-stimulating cell-wall component of bacteria), Pam(3)Cys-SKKKK (TLR2-stimulating synthetic peptide), poly I:C (TLR3-stimulating double-stranded RNA), concanavalin A (a typical T-cell mitogen and T-cell-mediated hepatitis-inducer), heat-killed Propionibacterium acnes (Gram-positive bacterium that causes pimples and induces macrophage-mediated experimental hepatitis), and nitrogen-containing bisphosphonates (chemicals stimulating IL-1 production). Unexpectedly, P. intermedia LPS, which displayed the most potent adjuvant activity among the tested preparations, was effective in TLR4-dysfunctional mutant mice, but not in TLR2-deficient mice, whereas the reverse was true for S. cerevisiae mannan. These results suggest that (i) for the establishment of Ni-allergy in mice, stimulation of innate immunity (including TLRs, NLRs, IL-1 production, and/or other factors) may be important at the sensitization step, and (ii) P. intermedia may produce a substance(s) that potently promotes Ni-allergy via stimulation of TLR2.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621645     DOI: 10.1016/j.intimp.2011.05.010

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

Review 1.  The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis.

Authors:  Joshua L Owen; Paras P Vakharia; Jonathan I Silverberg
Journal:  Am J Clin Dermatol       Date:  2018-06       Impact factor: 7.403

2.  Resin monomers act as adjuvants in Ni-induced allergic dermatitis in vivo.

Authors:  K Bando; H Takahashi; M Kinbara; Y Tanaka; T Kuroishi; K Sasaki; T Takano-Yamamoto; S Sugawara; Y Endo
Journal:  J Dent Res       Date:  2014-09-24       Impact factor: 6.116

Review 3.  Adaptation in the innate immune system and heterologous innate immunity.

Authors:  Stefan F Martin
Journal:  Cell Mol Life Sci       Date:  2014-07-06       Impact factor: 9.261

4.  Promotion of Nickel (Ni) Allergy by Anamnestic Sensitization with a Bacterial Component, Lipopolysaccharide (LPS), in Mice.

Authors:  Norimasa Adachi; Eiji Takayama; Makoto Adachi; Masako Mizuno-Kamiya; Harumi Kawaki; Hiroko Takeuchi; Shuri Kubo; Hajime Ishigami; Masakazu Kurachi; Nobuo Kondoh
Journal:  Open Dent J       Date:  2016-09-30

Review 5.  Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.

Authors:  Kurt Lucas; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-02-26       Impact factor: 5.590

6.  Contact allergy in children with and without atopic dermatitis: An Italian multicentre study.

Authors:  Domenico Bonamonte; Katharina Hansel; Paolo Romita; Anna Belloni Fortina; Giampiero Girolomoni; Gabriella Fabbrocini; Cataldo Patruno; Maddalena Napolitano; Annalisa Patrizi; Giuseppe Argenziano; Giuseppe Micali; Piergiacomo Calzavara Pinton; Caterina Foti; Luca Stingeni
Journal:  Contact Dermatitis       Date:  2022-04-28       Impact factor: 6.419

7.  Investigating the role of allergic contact dermatitis in residual ocular surface disease on dupilumab (ROSDD),.

Authors:  Jodie Raffi; Raagini Suresh; Harvey Fishman; Nina Botto; Jenny E Murase
Journal:  Int J Womens Dermatol       Date:  2019-11-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.